Ontology highlight
ABSTRACT:
SUBMITTER: Roviello G
PROVIDER: S-EPMC7321521 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Journal of oncology 20200619
<h4>Background</h4>Second line of treatment of hepatocellular carcinoma (HCC) has notably changed in recent years as three novel drugs with a different mechanism of action have demonstrated to improve survival compared to placebo; thus, there is a need to better define the profile of optimal candidates to second-line treatment with these drugs in order to maximize clinical benefit.<h4>Materials and methods</h4>We performed a pooled analysis from the subgroup analysis of all published phase III t ...[more]